EPAM Joins Sinequa’s Recently Introduced Partner Advantage Program
Newtown, PA and New York, NY – September 12, 2016 – EPAM Systems, Inc. (NYSE:EPAM), a leading global provider of product development and software engineering solutions, and Sinequa, a leader in Cognitive Search and Analytics and a founding sponsor of the Cognitive Computing Consortium, today announced a partnership to deliver search and analytics solutions for data-driven Global 2000 companies in the pharmaceutical industry. The combination of EPAM’s strong Big Data solutions practice and Sinequa’s unique Cognitive Search and Analytics platform offers customers the ability to gain quick, actionable insights from their structured and unstructured data.
With the emphasis on Big Data, predictive capabilities and speed of insights continue to transform the Life Sciences industry. The partnership enables organizations, facing the common challenge of effectively leveraging valuable insights extracted from large and diverse silos of data, to improve collaboration and streamline business operations. Customers will benefit from EPAM’s extensive Big Data expertise and their experience developing innovative, search-based applications on top of Sinequa’s platform. The partnership also allows customers to leverage best-in-class capabilities provided by Sinequa, including Natural Language Processing, Machine Learning, text mining, and powerful semantic analysis.
“As the Life Sciences industry continues to undergo unprecedented transformation to deliver more value-based and personalized medicine, the capability to integrate vast data resources and translate them into meaningful, actionable insights is critical,” said Richard Golob, Vice President, Global Head of Life Sciences, EPAM. “With that in mind, we are pleased to join Sinequa’s Partner Advantage Program, which will allow us to offer high-value solutions in areas of importance in Life Science R&D, as well as Big Data mining.”
“Our clients believe that digital transformation relies mostly on making information available faster with contextual insight,” said Xavier Pornain, Vice President, WW Sales and Alliances, Sinequa. “EPAM brings experienced scientists and experts to implement and quickly customize our unique Cognitive Search and Analytics platform, allowing our customers to extract new and useful business insights from the vast quantities of available data.”
About EPAM Systems
EPAM Systems, Inc. (NYSE: EPAM), a leading global product development and platform engineering services company, is focused on delivering results through best-in-class software engineering, combined with innovative strategy, consulting and design capabilities. With 23 years of experience in the information technology industry, EPAM’s 18,000 people serve our customers in over 25 countries across North America, Europe, Asia and Australia. EPAM was ranked #8 in FORBES 25 Fastest Growing Public Tech Companies and ranked as a top information technology services company on FORTUNE’S 100 Fastest Growing Companies.
Recognized as a leader in the Gartner Magic Quadrant for Enterprise Search and other analysts’ reports, Sinequa provides a cognitive search and analytics platform for Fortune Global 2000 companies and government agencies. Using advanced Natural Language Processing (NLP) and Machine Learning algorithms, the solution offers insights extracted from structured and unstructured data. Millions of users in the world's largest and most information-intensive organizations, including Airbus, AstraZeneca, Atos, Biogen, UCB, Credit Agricole, Mercer, and Siemens, rely on Sinequa to put business-critical information at the fingertips of their employees. Sinequa develops its expertise and its business around the world with a broad network of technology and business partners. Sinequa is a founding sponsor of the Cognitive Computing Consortium. For more information, http://www.sinequa.com.
This press release includes statements which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events that may not prove to be accurate. Factors that could cause actual results to differ materially from those expressed or implied include general economic conditions and the factors discussed in our most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. EPAM undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities law.